Form 4 holding
Chief Medical Officer
TScan Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 430,000
- Estimated value
- Report date
- 13 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount